Shanghai Junshi Biosciences Co. Ltd
Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China. The company was founded in 2012 and is headquartered in Shanghai, People's Republic of … Read more
Shanghai Junshi Biosciences Co. Ltd (SHJBF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.005x
Based on the latest financial reports, Shanghai Junshi Biosciences Co. Ltd (SHJBF) has a cash flow conversion efficiency ratio of -0.005x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-29.00 Million) by net assets ($6.29 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shanghai Junshi Biosciences Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Shanghai Junshi Biosciences Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Shanghai Junshi Biosciences Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Junshi Biosciences Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shanghai Baosight Software Co Ltd B
SHG:900926
|
0.057x |
|
Poonawalla Fincorp Limited
NSE:POONAWALLA
|
0.003x |
|
Kardex Holding AG
PINK:KRDXF
|
0.102x |
|
Tibet Urban Development and Investment Co Ltd
SHG:600773
|
-0.007x |
|
Inmobiliaria Colonial SOCIMI S.A.
LSE:0RID
|
0.023x |
|
Bank First National Corp
NASDAQ:BFC
|
-0.217x |
|
Duality Biotherapeutics, Inc.
F:4ZB
|
0.091x |
|
Hengbao Co Ltd
SHE:002104
|
0.011x |
Annual Cash Flow Conversion Efficiency for Shanghai Junshi Biosciences Co. Ltd (2014–2024)
The table below shows the annual cash flow conversion efficiency of Shanghai Junshi Biosciences Co. Ltd from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $5.95 Billion | $-1.44 Billion | -0.242x | +11.67% |
| 2023-12-31 | $7.34 Billion | $-2.01 Billion | -0.275x | -51.17% |
| 2022-12-31 | $9.78 Billion | $-1.78 Billion | -0.182x | -135.71% |
| 2021-12-31 | $8.33 Billion | $-641.90 Million | -0.077x | +69.98% |
| 2020-12-31 | $5.84 Billion | $-1.50 Billion | -0.257x | +35.40% |
| 2019-12-31 | $2.99 Billion | $-1.19 Billion | -0.397x | -158.27% |
| 2018-12-31 | $3.32 Billion | $-510.76 Million | -0.154x | +50.40% |
| 2017-12-31 | $1.12 Billion | $-347.08 Million | -0.310x | -88.62% |
| 2016-12-31 | $1.13 Billion | $-185.21 Million | -0.164x | -23.10% |
| 2015-12-31 | $614.22 Million | $-82.03 Million | -0.134x | -9.00% |
| 2014-12-31 | $319.87 Million | $-39.19 Million | -0.123x | -- |